US Undiscovered Gems to Watch in September 2025
As the U.S. stock market navigates a mix of record highs and economic uncertainties, small-cap stocks present intriguing opportunities for investors seeking growth potential amid fluctuating interest rates and inflation dynamics. In this environment, identifying lesser-known companies with strong fundamentals and innovative prospects can be key to uncovering hidden gems in the market.
Top 10 Undiscovered Gems With Strong Fundamentals In The United States
Name Debt To Equity Revenue Growth Earnings Growth Health Rating Morris State Bancshares NA 3.34% 3.70% ★★★★★★ Senstar Technologies NA -18.50% 29.50% ★★★★★★ ASA Gold and Precious Metals NA 12.79% -0.59% ★★★★★★ Metalpha Technology Holding NA 75.66% 28.60% ★★★★★★ FRMO 0.10% 42.87% 47.51% ★★★★★☆ Linkhome Holdings 7.03% 215.05% 239.56% ★★★★★☆ Rich Sparkle Holdings 26.73% -6.13% 1.75% ★★★★★☆ Elron Ventures 5.70% 13.72% 25.56% ★★★★☆☆ Greenfire Resources 35.48% -1.31% -25.79% ★★★★☆☆ Solesence 91.26% 23.30% 4.70% ★★★★☆☆
Click here to see the full list of 279 stocks from our US Undiscovered Gems With Strong Fundamentals screener.
Let's review some notable picks from our screened stocks.
Viemed Healthcare
Simply Wall St Value Rating: ★★★★★★
Overview: Viemed Healthcare, Inc. operates in the United States, offering home medical equipment and post-acute respiratory healthcare services, with a market capitalization of approximately $256 million.
Operations: Viemed generates revenue primarily from healthcare facilities and services, totaling $240.88 million. The company's financial performance is reflected in its net profit margin, which provides insight into profitability trends over time.
Viemed Healthcare, a player in the in-home ventilation market, has shown impressive growth with earnings rising 47.6% over the past year, outpacing the healthcare industry. The company's debt to equity ratio improved significantly from 12.7% to 3% over five years, indicating better financial health. Despite a one-off gain of US$3.5 million affecting recent results, Viemed's price-to-earnings ratio of 19.2x remains attractive compared to industry averages. Recent acquisitions like Lehan Medical Equipment bolster geographic reach and revenue potential while share repurchases totaling US$1.83 million reflect confidence in its future prospects despite regulatory challenges ahead.
Viemed Healthcare's strategic expansion and regulatory tailwinds enhance growth potential. Click here to explore Viemed's narrative further.VMD Debt to Equity as at Sep 2025
Fresh Del Monte Produce
Simply Wall St Value Rating: ★★★★★★
Overview: Fresh Del Monte Produce Inc. operates globally in the production, marketing, and distribution of fresh and fresh-cut fruits and vegetables, with a market cap of approximately $1.70 billion.
Story Continues
Operations: Fresh Del Monte's revenue is primarily driven by its Fresh and Value-Added Products segment, generating $2.64 billion, followed by the Banana segment at $1.48 billion. The company also earns $195.90 million from Other Products and Services.
Fresh Del Monte Produce, a notable player in the produce industry, is trading at a substantial discount of 40.5% below its estimated fair value. Over the past five years, the company has significantly reduced its debt-to-equity ratio from 33.3% to 9.7%, demonstrating strong financial discipline with a satisfactory net debt-to-equity ratio of 5.6%. Recent strategic moves include a joint venture with Managro Group to enhance avocado and lime supply chains in Colombia and an innovative partnership with CMA CGM for containerized shipping from the Philippines, which may bolster logistics efficiency and market reach amidst rising demand for nutrient-rich foods globally.
Fresh Del Monte Produce's earnings growth is challenged by unsustainable pricing strategies and climate risks. Click here to explore the full narrative on Fresh Del Monte Produce.FDP Earnings and Revenue Growth as at Sep 2025
Transcontinental Realty Investors
Simply Wall St Value Rating: ★★★★☆☆
Overview: Transcontinental Realty Investors, Inc., headquartered in Dallas, is a real estate investment company with a diverse U.S. portfolio of office buildings, apartments, shopping centers, and land holdings; it has a market cap of approximately $400.26 million.
Operations: Transcontinental Realty Investors generates revenue primarily from its multifamily and commercial real estate segments, with $34.18 million and $13.39 million, respectively.
Transcontinental Realty Investors, a small player in the real estate sector, has shown a satisfactory net debt to equity ratio of 23%, down from 133.6% over five years. While earnings have risen by 6.1% annually in that period, recent growth of 11.2% lagged behind the industry average of 13.8%. The company reported a one-off gain of US$4.2 million impacting its latest results up to June 2025, but free cash flow remains negative despite profitability not being an issue for cash runway concerns. Recent figures show second-quarter revenue at US$12.16 million with net income dipping to US$0.169 million from US$1.5 million last year, reflecting some volatility in performance metrics amidst ongoing market dynamics.
Get an in-depth perspective on Transcontinental Realty Investors' performance by reading our health report here. Gain insights into Transcontinental Realty Investors' historical performance by reviewing our past performance report.TCI Debt to Equity as at Sep 2025
Key Takeaways
Delve into our full catalog of 279 US Undiscovered Gems With Strong Fundamentals here. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.
Curious About Other Options?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include VMDFDP and TCI.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]
View Comments
Google